Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Klatskin Tumor × temoporfin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 1 Klatskin Tumor 1 Cholangiocarcinoma 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Fluorouracil 2 Capecitabine 2 tremelimumab 1 trametinib 1 temoporfin 1 durvalumab 1 dehydroftorafur 1 Sorafenib 1 Self Expandable Metallic Stents 1 Radiosurgery 1 Platinum 1 Oxaliplatin 1 N-Ac-CHAVC-NH2 1 Leucovorin 1 Hydroxychloroquine 1 Gemcitabine 1 Erlotinib Hydrochloride 1 Cisplatin 1 3-(4-chlorophenyl)-adamantane-1-carboxylic acid (pyridin-4-ylmethyl)amide 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03003065 2023-08-22

PDT

Chinese University of Hong Kong

Phase 2 Completed

Gastrointestinal

Neoplasms, Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡